Member Info for douve87

But it would serve a purpose. It would give confidence to the wider public. Show scancell is desirable and help show how the market values us. Offers should be made public.

I thought that too but I'm pretty sure that when Richard goodfellow was in charge he said he had received offers and they were never shared with the shareholders?

I thought I remembered that as well and wondered why we were never informed of the details? I thought if an offer was made we would have to be notified.

Hi CrustyPete, i was aware of that that's why I was asking at what stage would they have to inform us shareholders? Even if it was a low offer that was not acceptable to the BoD would they still need to inform us or as they have sufficient majority (share wise) could they just dismiss it and if not which (i assume they can't) how long after the offer is submitted for the BoD to make us shareholders aware? The reason i ask is even a low ball offer would be a shot in the arm for the SP and could help give us an indication of what is a fair price?

Quick question if partnership/ potential sale was being discussed at what stage would they have to inform shareholders? Even if the offer was far too low and the BoD recommended rejection I'm assuming we still need to be informed? Or can the BoD reject a low offer without informing us?

Not saying I believe them but I see a 13 and a 5 trade. If you believe in the MM code supposedly means:

13 - MM running out of inventory

5 - MM out of stock and can no longer lower price.

Anyone expecting news this week. I appreciate none of us on this forum know but anyone got a good feeling about news landing this week? If so are we thinking Thursday which seems to be the norm? Although I consider scan cell to run a tight ship whenever the share price starts to climb an rns usually follows close behind.

I've been invested since 2012 so don't think 6months in the grand scheme of things is that big. We be very pleased if that tarfet is met especially without dilution.

Big positive for me is the line that they still expect to start phase 3 in H2 2026. That doesn't sound like a company who has funding concerns. I appreciate until it's signed and sealed its not definite but they clearly still believe that timetable is realistic. I just wish I knew how they're expecting to fund it.

Happy new year everyone for what will hopefully be prosperous year for us all.

Apologies its lazy (not checking myself) but can someone remind me if we are expecting any updates in January? Thanks

If Chester is right and it is good news they are very good at keeping it quiet (judging by the shareprice slip today).

Think its a little early and a bit pessimistic to make this prediction. I think by the end of the year we will be in a better position to know whether further dilution is required/likely. You may well be right dracula and your welcome to your opinion (and you did caveat it with imo) but i do think its a good sign that Diggle has bought a million more. He is undoubtedly closer to what is happening at scancell than us and has chosen to buy which suggests to me a fundraise/dilution is unlikely imminently otherwise you'd wait for the fundraise. Its not a guarantee, but personally take Diggle's recent purchase as a good sign.

Sorry if being dim or have missed something. What's her connection to scancell? Why do you think she maybe a new hire for investor relations?

I prefer this bit ( in relation to creation of GT) "The timing reflects the progress of the lead wholly owned GlyMab asset, SC134, through preclinical development and the expectation that an IND to start clinical studies will be filed within the year." And the milestone payment (whatever they may be that will come with this).

I may be wrong but moving the glymabs into GT also makes scib and modi tidier. I.e if someone wanted to invest heavily/buy the scib/modi platform following the results by the end of the year then it allows Lindy to continue with the glymabs. The point I'm trying to make is the setup of GT doesn't necessarily have to be down to the sale of the glymabs? Just a thought

Although a shame that the trials failed because ultimately we all want a cure or failing that effective treatments for cancer. Selfishly this would on the face be positive for Scancell assuming our trials are progressing as hoped. Before anyone thinks im getting carried away or becoming a happy clappy member i do recognise there will be countless other studies not scancell being continued at this moment which i hope will/are successful as well (just hopefully not as successful as scancell lol).

BuddhaBob, i hope youre right and you will have no argument from me that the shareprice so be much higher then it is now. But I dont agree that 'the higher the pre news price the higher the jump on news.' The amount of shares ive seen rise on speculation and then drop when news announced(even when its good news but maybe not as good as hoped), equally ive seen prices rise on bad news when the speculation was worse than the reality of the news.

We undoubtedly should be higher and i hope youre right. Where a higher share price def leads to higher returns is when the news concerns a company takeover. In which case the higher the sp before an offer comes in the better. Im not trying to be contrary but have been disappointed in the past.

Looking at agenda for the conference the modi 2 talk was yesterday. So i guess no new news was released so i wouldnt expect a rns.

Interesting article about aim listed companies going to nasdaq. 11 of the 13 in the article are now trading at less than when they joined nasdaq. So grass isn't always greener.

https://www.ii.co.uk/analysis-commentary/when-companies-leave-aim-nasdaq-grass-greener-ii528399

Ive still yet to get my offer which i will vote against. Im with iweb. Has everyone else got their offer yet?